XML 116 R62.htm IDEA: XBRL DOCUMENT v3.25.0.1
Segment and Enterprise Reporting (Tables)
 12 Months Ended
Dec. 28, 2024
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
Selected information by reportable segment is presented below for the years ended December 28, 2024, December 30, 2023 and December 31, 2022:
(in millions)Year Ended
December 28,
2024		Year Ended
December 30,
2023		Year Ended
December 31,
2022
Revenues by segment:
Healthcare$1,395.2 $1,275.5 $1,340.3 
Non-healthcare699.2 772.6 695.5 
Revenue
$2,094.4 $2,048.1 $2,035.8 
Cost of goods sold by segment:
Healthcare$520.7 $498.4 $470.1 
Healthcare other(1)
80.2 11.5 2.4 
Non-healthcare463.9 514.6 443.0 
Non-healthcare other(1)
25.2 20.1 61.5 
Cost of goods sold$1,090.0 $1,044.6 $977.0 
Gross profit:$1,004.4 $1,003.5 $1,058.8 
Healthcare
Segment gross profit
$874.5 $777.1 $870.2 
Acquired asset amortization(1)(2)
(1.8)(2.0)(2.3)
Business transition and related costs(1)(3)
(77.1)(5.6)(0.1)
Other(1)
(1.3)(3.9)— 
Non-healthcare
Segment gross profit235.3 258.0 252.5 
Acquired asset amortization(1)(2)
(17.7)(19.7)(61.5)
Business transition and related costs(1)(3)
(7.5)(0.4)— 
__________________
(1)     Management excludes certain expenses from segment gross profit. Management considers these excluded amounts to be non-recurring or non-operational and as such, are excluded from segment gross profit as this enables management to better understand operational results.
(2)     Acquired asset amortization is a non-GAAP financial measure. These transactions represent amortization expense in connection with business or assets acquisitions associated with acquired intangible assets including, but not limited to customer relationships, intellectual property, trade names and non-competition agreements.
(3)     Business transition and related costs are a non-GAAP financial measure. These transactions represent gains, losses, and other related costs associated with business transition plans. These items may include but are not limited to severance, relocation, consulting, leasehold exit costs, asset impairment, and other related costs to rationalize our operational footprint and optimize business results.
The Company’s depreciation and amortization by segment are as follows:
(in millions)Year Ended
December 28,
2024		Year Ended
December 30,
2023		Year Ended
December 31,
2022
Total depreciation and amortization by segment:
Healthcare$48.7 $38.1 $36.0 
Non-healthcare54.3 60.1 100.1 
Total depreciation and amortization by segment
$103.0 $98.2 $136.1 
The Company’s total assets by segment are as follows:
(in millions)December 28,
2024		December 30,
2023
Total assets by segment:
Healthcare$1,601.1 $1,631.8 
Non-healthcare1,007.2 1,390.6 
Asset held-for-sale
17.4 — 
Corporate overhead— 19.1 
Total assets by segment$2,625.7 $3,041.5 
The Company’s consolidated long-lived assets (tangible non-current assets) by geographic area are as follows:
(in millions, except percentages)
Year Ended
December 28,
2024		Year Ended
December 30,
2023
Total long-lived assets by geographic area:
United States$319.7 79.9 %$317.9 74.6 %
International80.6 20.1 108.0 25.4 
Total long-lived assets by geographic area$400.3 100.0 %$425.9 100.0 %
The following schedule presents an analysis of the Company’s revenues based upon the geographic area (ship to location):
(in millions, except percentages)
Year Ended
December 28,
2024		Year Ended
December 30,
2023		Year Ended
December 31,
 2022
Total revenue by geographic area:
United States (U.S.)$1,127.6 53.8 %$1,058.8 51.8 %$1,141.7 56.1 %
Europe, Middle East and Africa595.6 28.4 571.9 27.9 523.6 25.7 
Asia and Australia303.5 14.5 351.0 17.1 326.8 16.1 
North and South America (excluding U.S.)67.7 3.3 66.4 3.2 43.7 2.1 
     Total revenue by geographic area$2,094.4 100.0 %$2,048.1 100.0 %$2,035.8 100.0 %